Medical device company NinePoint Medical, Inc revealed on Sunday the addition of Eman Namati, PhD as its president and chief executive officer.
The company said Dr Namati succeeds Christopher von Jako, PhD, who will continue to serve on the board of directors as an independent member.
In the senior positions in the company, Dr Namati will assume day-to-day leadership, while working in collaboration with Merit Medical Systems Inc (NASDAQ:MMSI), who now manages the sales distribution and customer service for the NvisionVLE Imaging System, which provides a unique and clinically valuable new perspective on esophageal disease.
Prior to the promotion, Dr Namati was a technical co-founder as well as vice president of Research and Development at the company, which he joined in 2010.
Previously, Dr Namati was a researcher developing optical imaging systems at Massachusetts General Hospital.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system